GlobeNewswire
Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia
A World-First, Fully Synthetic Recombinant Version of PRPMELBOURNE, , Jan. 20, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Pro...
Foresight: Eye-Net and SoftBank Corp. Advance Strategic Collaboration in Japan
Parties are collaborating in a multi-phase plan to assess Eye-Net’s collision prevention V2X technology to protect both vehicles and vulnerable road u...
MetalBear Launches mirrord for CI to Bring Production-Like Testing into Continuous Integration
New capability extends mirrord’s environment mirroring into CI pipelines, enabling teams to run tests against real, shared Kubernetes environments wit...
Uni-Fuels Enhances End-to-end EU ETS Compliance Solutions for Global Shipping Companies with EU Allowance Support
SINGAPORE, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited (NASDAQ: UFG) (“Uni-Fuels” or the “Company”), a global provider of marine fu...
Fast Track Events Rebrands to Fast Track Entertainment, Marking a Strategic Evolution Beyond Events
Corporate rebrand reinforces the Company’s ambition to shape global entertainment from Asia, creating influence that lives on long after the lights go...
ZOOZ Reports Preliminary 2025 Financial Information, Cash and Bitcoin Positions and Additional Corporate Updates
TEL AVIV, Israel, Jan. 20, 2026 (GLOBE NEWSWIRE) -- ZOOZ Strategy Ltd. (Nasdaq and TASE: ZOOZ) today announced its cash and debt positions as of Dec...
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent...
PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast Accuracy
Patent filing follows acceptance into the NVIDIA Connect Program Proprietary software targets weather forecast-driven revenue optimization, reduced...
Nasus Pharma Announces Positive Interim Results from Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to EpiPen® 91% of study part...
Genius Group Launches Genius School as a Model Future School, to Prepare Students for a Post-Singularity World
SINGAPORE, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bit...
iOThree Limited’s V.Secure Achieves IACS UR E27 Type Approval from RINA
Certification affirms compliance with international cyber-resilience standards for onboard computer-based systems SINGAPORE, Jan. 20, 2026 (GLOBE N...
3 E Network Accelerates Nordic Strategy with Planned Deployment of High-Density AI Computing Infrastructure in Finland
HONG KONG, Jan. 20, 2026 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3 E Network”), a business-to-bus...